Raymond James Trust’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.62M | Sell |
25,253
-197
| -0.8% | -$20.1K | 0.06% | 283 |
|
|
2024
Q2 | $2.47M | Sell |
25,450
-1,651
| -6% | -$152K | 0.06% | 278 |
|
|
2024
Q1 | $2.44M | Sell |
27,101
-1,381
| -5% | -$117K | 0.06% | 276 |
|
|
2023
Q4 | $2.27M | Buy |
28,482
+2,565
| +10% | +$193K | 0.06% | 270 |
|
|
2023
Q3 | $1.84M | Sell |
25,917
-364
| -1% | -$27.2K | 0.05% | 292 |
|
|
2023
Q2 | $2.02M | Sell |
26,281
-118
| -0.4% | -$9.13K | 0.06% | 275 |
|
|
2023
Q1 | $1.98M | Buy |
26,399
+1,320
| +5% | +$98.2K | 0.06% | 261 |
|
|
2022
Q4 | $1.98M | Sell |
25,079
-216
| -0.9% | -$16.2K | 0.07% | 251 |
|
|
2022
Q3 | $1.78M | Sell |
25,295
-2,234
| -8% | -$175K | 0.07% | 257 |
|
|
2022
Q2 | $2.21M | Sell |
27,529
-1,441
| -5% | -$113K | 0.08% | 229 |
|
|
2022
Q1 | $2.2M | Buy |
28,970
+439
| +2% | +$34.8K | 0.07% | 253 |
|
|
2021
Q4 | $2.44M | Sell |
28,531
-1,546
| -5% | -$121K | 0.07% | 235 |
|
|
2021
Q3 | $2.27M | Buy |
30,077
+241
| +0.8% | +$19.1K | 0.08% | 227 |
|
|
2021
Q2 | $2.43M | Sell |
29,836
-3,200
| -10% | -$262K | 0.08% | 213 |
|
|
2021
Q1 | $2.6M | Buy |
33,036
+4,284
| +15% | +$336K | 0.09% | 195 |
|
|
2020
Q4 | $2.46M | Buy |
28,752
+1,096
| +4% | +$90.6K | 0.09% | 187 |
|
|
2020
Q3 | $2.13M | Buy |
27,656
+1,557
| +6% | +$119K | 0.09% | 189 |
|
|
2020
Q2 | $1.91M | Sell |
26,099
-734
| -3% | -$52.1K | 0.09% | 189 |
|
|
2020
Q1 | $1.78M | Buy |
26,833
+715
| +3% | +$50.4K | 0.11% | 169 |
|
|
2019
Q4 | $1.8M | Buy |
26,118
+371
| +1% | +$25.3K | 0.09% | 203 |
|
|
2019
Q3 | $1.89M | Buy |
25,747
+496
| +2% | +$36K | 0.1% | 196 |
|
|
2019
Q2 | $1.81M | Sell |
25,251
-303
| -1% | -$21.5K | 0.1% | 193 |
|
|
2019
Q1 | $1.75M | Buy |
25,554
+1,348
| +6% | +$87.1K | 0.1% | 192 |
|
|
2018
Q4 | $1.44M | Sell |
24,206
-2,164
| -8% | -$135K | 0.09% | 210 |
|
|
2018
Q3 | $1.77M | Sell |
26,370
-51
| -0.2% | -$3.4K | 0.1% | 199 |
|
|
2018
Q2 | $1.71M | Buy |
26,421
+3,986
| +18% | +$261K | 0.1% | 201 |
|
|
2018
Q1 | $1.61M | Buy |
22,435
+1,909
| +9% | +$137K | 0.11% | 188 |
|
|
2017
Q4 | $1.55M | Sell |
20,526
-1,201
| -6% | -$87.7K | 0.1% | 196 |
|
|
2017
Q3 | $1.58M | Sell |
21,727
-1,646
| -7% | -$119K | 0.11% | 188 |
|
|
2017
Q2 | $1.73M | Buy |
23,373
+1,966
| +9% | +$146K | 0.13% | 173 |
|
|
2017
Q1 | $1.57M | Buy |
21,407
+1,968
| +10% | +$138K | 0.12% | 183 |
|
|
2016
Q4 | $1.27M | Sell |
19,439
-690
| -3% | -$47.3K | 0.1% | 199 |
|
|
2016
Q3 | $1.49M | Sell |
20,129
-169
| -0.8% | -$12.5K | 0.13% | 163 |
|
|
2016
Q2 | $1.49M | Buy |
20,298
+2,499
| +14% | +$178K | 0.13% | 162 |
|
|
2016
Q1 | $1.26M | Sell |
17,799
-2,500
| -12% | -$166K | 0.12% | 175 |
|
|
2015
Q4 | $1.35M | Buy |
20,299
+2,883
| +17% | +$192K | 0.12% | 169 |
|
|
2015
Q3 | $1.1M | Sell |
17,416
-280
| -2% | -$18.3K | 0.12% | 167 |
|
|
2015
Q2 | $1.16M | Sell |
17,696
-455
| -3% | -$30.9K | 0.12% | 173 |
|
|
2015
Q1 | $1.26M | Buy |
18,151
+361
| +2% | +$25K | 0.13% | 165 |
|
|
2014
Q4 | $1.23M | Buy |
17,790
+1,160
| +7% | +$78.3K | 0.13% | 169 |
|
|
2014
Q3 | $1.08M | Sell |
16,630
-928
| -5% | -$61.2K | 0.12% | 178 |
|
|
2014
Q2 | $1.2M | Sell |
17,558
-1,365
| -7% | -$91.5K | 0.14% | 153 |
|
|
2014
Q1 | $1.23M | Sell |
18,923
-5,335
| -22% | -$336K | 0.15% | 146 |
|
|
2013
Q4 | $1.58M | Buy |
24,258
+739
| +3% | +$47.3K | 0.21% | 116 |
|
|
2013
Q3 | $1.4M | Buy |
23,519
+329
| +1% | +$19.5K | 0.21% | 118 |
|
|
2013
Q2 | $1.33M | Buy |
+23,190
| New | +$1.38M | 0.22% | 116 |
|
Other funds holding CL
Raymond James Trust's CL Position: Q3 2024 in Review
Raymond James Trust reduced its Colgate-Palmolive (CL) stake by 0.77% in Q3 2024, selling an estimated $20.1K and leaving 25,253 shares worth $2.62M. The position accounts for 0.06% of the portfolio, ranked #283.
Raymond James Trust first reported a position in CL in Q2 2013 and has held it in 46 quarters since. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.
- Raymond James Trust held 25,253 shares of Colgate-Palmolive worth $2.62M as of Q3 2024.
- Raymond James Trust sold 197 Colgate-Palmolive shares in Q3 2024, an estimated $20.1K.
- Colgate-Palmolive made up 0.06% of Raymond James Trust's portfolio in Q3 2024, its #283 holding.
- Raymond James Trust first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 46 quarters since.
- 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.